Vanguard Group Inc Kempharm, Inc Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Kempharm, Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,756,061 shares of KMPH stock, worth $13.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,756,061
Previous 1,833,415
50.32%
Holding current value
$13.6 Million
Previous $9.06 Million
50.31%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding KMPH
# of Institutions
117Shares Held
26.1MCall Options Held
591KPut Options Held
242K-
Woodline Partners LP San Francisco, CA4.05MShares$20 Million0.18% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.92MShares$14.4 Million0.86% of portfolio
-
Black Rock Inc. New York, NY2.7MShares$13.3 Million0.0% of portfolio
-
Altium Capital Management LP New York, NY1.7MShares$8.4 Million2.96% of portfolio
-
683 Capital Management, LLC New York, NY1.23MShares$6.05 Million0.55% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...